Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Expanded_access × Lymphangioma × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 4 Observational 2 Expanded_access 1

Sponsor

Conditions

Prostatic Neoplasms 14 Neuroblastoma 9 Neoplasms 9 Recurrence 6 Lambert-Eaton Myasthenic Syndrome 6 Carcinoma, Hepatocellular 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Pheochromocytoma 5 Multiple Myeloma 5 Lymphoma 5 Leukemia 5 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Sarcoma 3 Paraganglioma 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Myelodysplastic Syndromes 3 Liver Neoplasms 3 Insulinoma 3 Immunologic Deficiency Syndromes 3 Hematologic Neoplasms 3 Glioma 3 Carcinoid Tumor 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Precancerous Conditions 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

New Mexico Cancer Research Alliance

No longer available

Lymphangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡